seborrheic dermatitis
seborrheic dermatitis
Explore linked clinical trials. Standard reference: MONDO:00066086 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TRIDERM D.S. Crema Normalizzante for Neonatal Hyperseborrhea (Cradle Cap) and Associated Cutaneous Manifestations of Mild-to-Moderate Seborrheic Dermatitis in Children Aged 0 to 3 Years | Erythema, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Diseases, Eczematous, Skin Diseases, Papulosquamous, Skin Manifestations, Skin and Connective Tissue Diseases, complement component 5 deficiency, dermatitis, sebaceous gland disorder, seborrheic dermatitis, skin disorder | Not yet recruiting | Not applicable | 2026-10-06 | NCT07860788 | |
| Efficacy and Safety of Roflumilast Foam 0.3% in Trial Participants With Seborrheic Dermatitis | Skin Diseases, Eczematous, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, dermatitis, sebaceous gland disorder, seborrheic dermatitis, skin disorder | Not yet recruiting | Phase 3 | 2026-08-21 | NCT07683806 | |
| The Effectiveness of Itraconazole Pulse Therapy vs Topical 2% Ketoconazole in the Treatment of Moderate to Severe Seborrheic Dermatitis of Scalp. | Skin Diseases, Eczematous, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, dermatitis, sebaceous gland disorder, seborrheic dermatitis, skin disorder | Recruiting | Early phase 1 | 2026-07-29 | NCT07734441 | |
| ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis | Skin Diseases, Eczematous, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, dermatitis, sebaceous gland disorder, seborrheic dermatitis, skin disorder | Recruiting | Phase 1 | 2026-06-17 | NCT07404033 | |
| A Study on Scalp Health and Integrated Scalp Management Protocols for Hair Transplant Patients | Skin Diseases, Eczematous, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, dermatitis, sebaceous gland disorder, seborrheic dermatitis, skin disorder | Recruiting | Not applicable | 2026-06-11 | NCT07641686 | |
| Sebum Metabolomics and Lipidomics for Clinical Applications | Acneiform Eruptions, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, acne, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, psoriasis, sebaceous gland disorder, seborrheic dermatitis, skin disorder | Not yet recruiting | Not applicable | 2026-04-24 | NCT07549828 |